Indoleamine 2,3-Dioxygenase Activity and Expression in Patients With Chronic Lymphocytic Leukemia
Authors:
- Vesa LindströmVLVesa Lindström
- Janne AittoniemiJAJanne Aittoniemi
- Juulia JylhäväJJJuulia Jylhävä
- Carita EklundCECarita Eklund
- Mikko HurmeMHMikko Hurme
- Timo PaavonenTPTimo Paavonen
- Simo S. OjaSOSimo S. Oja
- Maija Itälä-RemesMIMaija Itälä-Remes
- Marjatta SinisaloMSMarjatta Sinisalo
- 1 October 2012
- journal article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 12 (5) , 363-365
Abstract
No abstract availableKeywords
Funding Information
- Medical Research Fund of Pirkanmaa Hospital District
This publication has 23 references indexed in Scilit:
- Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathwayThe International Journal of Biochemistry & Cell Biology, 2009
- Antibody response to 7-valent conjugated pneumococcal vaccine in patients with chronic lymphocytic leukaemiaVaccine, 2007
- Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and miceGene, 2007
- Indoleamine 2,3-dioxygenase and tumor-induced toleranceJournal of Clinical Investigation, 2007
- Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2005
- Dendritic Cells from Chronic Lymphocytic Leukemia Patients Are Normal Regardless of Ig V Gene Mutation StatusMolecular Medicine, 2004
- Vaccination Against Infections in Chronic Lymphocytic LeukemiaLeukemia & Lymphoma, 2003
- Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?Immunology Today, 1999
- B-Cell Chronic Lymphocytic Leukemia: A Bird of a Different FeatherJournal of Clinical Oncology, 1999
- Localization of indoleamine 2,3-dioxygenase gene (INDO) to chromosome 8p12→p11 by fluorescent in situ hybridizationCytogenetic and Genome Research, 1993